Disparate effects of endostatin on tumor vascular perfusion and hypoxia in two murine mammary carcinomasFENTON, Bruce M; PAONI, Scott F; GRIMWOOD, Brian G et al.International journal of radiation oncology, biology, physics. 2003, Vol 57, Num 4, pp 1038-1046, issn 0360-3016, 9 p.Article

Urotensin-II as an angiogenic factorGUIDOLIN, Diego; ALBERTIN, Giovanna; RIBATTI, Domenico et al.Peptides (New York, NY. 1980). 2010, Vol 31, Num 6, pp 1219-1224, issn 0196-9781, 6 p.Article

Antiangiogenic Effects and Mechanisms of trans-Ethyl p-Methoxycinnamate from Kaempferia galonga LHE, Zhi-Heng; GAR-LEE YUE, Grace; BIK-SAN LAU, Clara et al.Journal of agricultural and food chemistry (Print). 2012, Vol 60, Num 45, pp 11309-11317, issn 0021-8561, 9 p.Article

δ-Tocotrienol Suppresses VEGF Induced Angiogenesis whereas α-Tocopherol Does NotSHIBATA, Akira; NAKAGAWA, Kiyotaka; SOOKWONG, Phumon et al.Journal of agricultural and food chemistry (Print). 2009, Vol 57, Num 18, pp 8696-8704, issn 0021-8561, 9 p.Article

Antiangiogenic and anticancer potential of unsaturated vitamin E (tocotrienol)MIYAZAWA, Teruo; SHIBATA, Akira; SOOKWONG, Phumon et al.Journal of nutritional biochemistry. 2009, Vol 20, Num 2, pp 79-86, issn 0955-2863, 8 p.Article

Synthesis and antimitotic activity of novel 2-methoxyestradiol analogs. Part IIIRAO, Pemmaraju N; CESSAC, James W; BOYD, James W et al.Steroids. 2008, Vol 73, Num 2, pp 171-183, issn 0039-128X, 13 p.Article

The discovery of the placental growth factor and its role in angiogenesis : a historical reviewRIBATTI, Domenico.Angiogenesis (London). 2008, Vol 11, Num 3, pp 215-221, issn 0969-6970, 7 p.Article

Lesional expression of the endogenous angiogenesis inhibitor endostatin/ collagen XVIII following traumatic brain injury (TBI)MUELLER, C. A; SCHLUESENER, H. J; FAUSER, U et al.Experimental neurology (Print). 2007, Vol 208, Num 2, pp 228-237, issn 0014-4886, 10 p.Article

Pharmacokinetic and pharmacodynamic study of intratumoral injection of an adenovirus encoding endostatin in patients with advanced tumorsLI, H.-L; LI, S; GUAN, Z.-Z et al.Gene therapy (Basingstoke). 2008, Vol 15, Num 4, pp 247-256, issn 0969-7128, 10 p.Article

Therapeutic renaissance of thalidomide in the treatment of haematological malignanciesRIBATTI, D; VACCA, A.Leukemia. 2005, Vol 19, Num 9, pp 1525-1531, issn 0887-6924, 7 p.Article

Syntheses and biological activities of polymers containing methacryloyl-2-oxy-1,2,3-propanetricarboxylic acid or 5-fluorouracilLEE, Sun-Mi; LEE, Neung-Ju; HA, Chang-Sik et al.Journal of applied polymer science. 2004, Vol 94, Num 1, pp 57-64, issn 0021-8995, 8 p.Article

Antiangiogenic effect of bile acid acylated heparin derivativePARK, Kyeongsoon; KIM, Yoo-Shin; GEE YOUNG LEE et al.Pharmaceutical research. 2007, Vol 24, Num 1, pp 176-185, issn 0724-8741, 10 p.Article

Intra-arterial delivery of endostatin gene to brain tumors prolongs survival and alters tumor vessel ultrastructureBARNETT, F. H; SCHARER-SCHUKSZ, M; WOOD, M et al.Gene therapy (Basingstoke). 2004, Vol 11, Num 16, pp 1283-1289, issn 0969-7128, 7 p.Article

A heteropolysaccharide, L-fuco-D-manno-1,6-α-D-galactan extracted from Grifola frondosa and antiangiogenic activity of its sulfated derivativeYING WANG; XIAOKUN SHEN; WENFENG LIAO et al.Carbohydrate polymers. 2014, Vol 101, pp 631-641, issn 0144-8617, 11 p.Article

Induction of Apoptosis and Inhibition of Angiogenesis by PEGylated Liposomal Quercetin in Both Cisplatin-Sensitive and Cisplatin-Resistant Ovarian CancersQIDA LONG; YAO XIE; CHANGYANG GONG et al.Journal of biomedical nanotechnology (Print). 2013, Vol 9, Num 6, pp 965-975, issn 1550-7033, 11 p.Article

Dihydroartemisinin inhibits angiogenesis in pancreatic cancer by targeting the NF-κB pathwayWANG, Shuang-Jia; BEI SUN; BAI, Xue-Wei et al.Cancer chemotherapy and pharmacology. 2011, Vol 68, Num 6, pp 1421-1430, issn 0344-5704, 10 p.Article

High antiangiogenic and low anticoagulant efficacy of orally active low molecular weight heparin derivativesJIN WOO PARK; OK CHEOL JEON; SANG KYOON KIM et al.Journal of controlled release. 2010, Vol 148, Num 3, pp 317-326, issn 0168-3659, 10 p.Article

Epoxyquinol B Shows Antiangiogenic and Antitumor Effects by Inhibiting VEGFR2, EGFR, FGFR, and PDGFRKAMIYAMA, Hiroshi; KAKEYA, Hideaki; USUI, Takeo et al.Oncology research. 2008, Vol 17, Num 1, pp 11-21, issn 0965-0407, 11 p.Article

Using behavioral measurement to assess tumor progression and functional outcome after antiangiogenic treatment in mouse glioma modelsHONGYAN YANG; CHOPP, Michael; XUEPENG ZHANG et al.Behavioural brain research. 2007, Vol 182, Num 1, pp 42-50, issn 0166-4328, 9 p.Article

Phase II trial of copper depletion with tetrathiomolybdate as an antiangiogenesis strategy in patients with hormone-refractory prostate cancerHENRY, N. Lynn; DUNN, Rodney; MERJAVER, Sofia et al.Oncology. 2006, Vol 71, Num 3-4, pp 168-175, issn 0030-2414, 8 p.Article

A dose-finding and pharmacokinetic study of the matrix metalloproteinase inhibitor MM1270 (previously termed CGS27023A) with 5-FU and folinic acidEATOCK, M; CASSIDY, J; JOHNSON, J et al.Cancer chemotherapy and pharmacology. 2005, Vol 55, Num 1, pp 39-46, issn 0344-5704, 8 p.Article

Current perspectives on antiangiogenesis strategies in the treatment of malignant gliomasJANSEN, Marnix; DE WITT HAMER, Philip C; WITMER, Antonella N et al.Brain research reviews. 2004, Vol 45, Num 3, pp 143-163, issn 0165-0173, 21 p.Article

Different combination schedules of gemcitabine with endostar affect antitumor efficacyPENG, Xing-Chen; MENG QIU; GONG, Feng-Ming et al.Cancer chemotherapy and pharmacology. 2012, Vol 69, Num 1, pp 239-246, issn 0344-5704, 8 p.Article

Discovery of novel taspine derivatives as antiangiogenic agentsJIE ZHANG; YANMIN ZHANG; SANQI ZHANG et al.Bioorganic & medicinal chemistry letters (Print). 2010, Vol 20, Num 2, pp 718-721, issn 0960-894X, 4 p.Article

A phase I dose escalation study of the pharmacokinetics and tolerability of ZK 304709, an oral multi-targeted growth inhibitor (MTGI^™), in patients with advanced solid tumoursSCOTT, Edwina N; THOMAS, Anne L; DE BONO, Johann et al.Cancer chemotherapy and pharmacology. 2009, Vol 64, Num 2, pp 425-429, issn 0344-5704, 5 p.Article